StemCell Institute Inc.
7096.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥14 | ¥19 | ¥26 | ¥20 |
| - Cash | ¥3 | ¥3 | ¥3 | ¥4 |
| + Debt | ¥1 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥11 | ¥16 | ¥22 | ¥17 |
| Revenue | ¥3 | ¥2 | ¥2 | ¥2 |
| % Growth | 8% | 18.6% | 17.4% | – |
| Gross Profit | ¥2 | ¥2 | ¥1 | ¥1 |
| % Margin | 63.2% | 63.5% | 63.9% | 62.4% |
| EBITDA | ¥1 | ¥1 | ¥0 | ¥0 |
| % Margin | 25.9% | 21.5% | 19.2% | 17.4% |
| Net Income | ¥0 | ¥0 | ¥0 | ¥0 |
| % Margin | 14.4% | 12.5% | 9.5% | 7.5% |
| EPS Diluted | 37.67 | 30.25 | 19.33 | 13.2 |
| % Growth | 24.5% | 56.5% | 46.4% | – |
| Operating Cash Flow | ¥0 | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | -¥0 | -¥0 | -¥0 | -¥0 |
| Free Cash Flow | -¥0 | ¥0 | ¥0 | ¥0 |